These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1976558)

  • 1. Fasting and postprandial concentrations of somatostatin-28 and somatostatin-14 in type II diabetes in men.
    D'Alessio DA; Ensinck JW
    Diabetes; 1990 Oct; 39(10):1198-202. PubMed ID: 1976558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action.
    Gutniak M; Grill V; Efendić S
    J Clin Endocrinol Metab; 1986 Jan; 62(1):77-83. PubMed ID: 2866196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma somatostatin-like immunoreactivity responses to a mixed meal and the heterogeneity in healthy and non-insulin-dependent (NIDDM) diabetics.
    Miyazaki K; Funakoshi A; Ibayashi H
    Endocrinol Jpn; 1986 Feb; 33(1):51-9. PubMed ID: 2873028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal and meal-induced somatostatin-like immunoreactivity in healthy subjects and in IDDM and totally pancreatectomized patients. Effects of acute blood glucose normalization.
    Gutniak M; Grill V; Wiechel KL; Efendić S
    Diabetes; 1987 Jul; 36(7):802-7. PubMed ID: 2884157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma somatostatin-like immunoreactivity and somatostatin-28 levels in obese men.
    Peracchi M; Carola F; Cavagnini F; Benti R; Bareggi B; Baccalaro G; Basilisco G
    J Endocrinol Invest; 1998 Jan; 21(1):20-3. PubMed ID: 9633018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose infusion of somatostatin in man--no effect upon intestinal calcium absorption but a fall in blood insulin.
    Rümenapf G; Hanisch E; Schwille PO
    Exp Clin Endocrinol; 1986 Aug; 87(3):306-12. PubMed ID: 2877894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating somatostatin concentrations in healthy and non-insulin-dependent (type II) diabetic subjects.
    Conlon JM; McCulloch AJ; Alberti KG
    Diabetes; 1983 Aug; 32(8):723-9. PubMed ID: 6347769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics.
    Baron AD; Schaeffer L; Shragg P; Kolterman OG
    Diabetes; 1987 Mar; 36(3):274-83. PubMed ID: 2879757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of low-dose somatostatin infusion on pancreatic and gastric endocrine function in lean and obese nondiabetic human subjects.
    Schusdziarra V; Lawecki J; Ditschuneit HH; Lukas B; Maier V; Pfeiffer EF
    Diabetes; 1985 Jun; 34(6):595-601. PubMed ID: 2861127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin potentiation of insulin-induced glucose uptake in normal individuals.
    Wu MS; Ho LT; Chen JJ; Chen YD; Reaven GM
    Am J Physiol; 1986 Dec; 251(6 Pt 1):E674-9. PubMed ID: 2878619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of somatostatin-induced suppression of postprandial insulin response upon the hypertriglyceridemia associated with a high carbohydrate diet.
    Ginsberg HN; Jacobs A; Le NA; Sandler J
    J Clin Invest; 1982 Dec; 70(6):1225-33. PubMed ID: 6129260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of somatostatin in regulating pancreatic splenic lobe hormone secretion following 99% pancreatectomy in adult chickens.
    Cieslak SR; Hazelwood RL
    Gen Comp Endocrinol; 1986 Aug; 63(2):284-94. PubMed ID: 2877920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of guar intake on plasma somatostatin-like immunoreactivity in diabetic patients.
    Shimoyama R; Uehara S; Itagaki Y; Izumiyama S; Hirayama A
    Hokkaido Igaku Zasshi; 1982 Nov; 57(6):727-33. PubMed ID: 6134660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Somatostatin-like activity (SLI) in the blood during metformin treatment of obese patients with diabetes mellitus type 2].
    Lawecki J; Stryjek-Kamińska D; Schusdziarra V
    Pol Arch Med Wewn; 1989 Mar; 81(3):183-8. PubMed ID: 2576469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A stimulating effect of glucose on somatostatin release is impaired in noninsulin-dependent diabetes mellitus.
    Grill V; Gutniak M; Roovete A; Efendić S
    J Clin Endocrinol Metab; 1984 Aug; 59(2):293-7. PubMed ID: 6145723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance of growth hormone secretion to somatostatin in men with type I diabetes mellitus.
    Cohen RM; Abplanalp WA
    Diabetes; 1991 Oct; 40(10):1251-8. PubMed ID: 1682193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pancreatic glucagon and C-peptide secretion during hyperinsulinemia in euglycemic glucose clamp with or without somatostatin infusion in normal man.
    Wu MS; Ho LT
    Horm Metab Res; 1987 Jun; 19(6):253-6. PubMed ID: 2887501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of plasma somatostatin-like immunoreactivity (SLI) to a 75 g oral glucose tolerance test in normal subjects and patients with impaired glucose tolerance.
    Itoh M; Hirooka Y; Nihei N
    Acta Endocrinol (Copenh); 1983 Dec; 104(4):468-74. PubMed ID: 6140806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon does not increase plasma free fatty acid and glycerol concentrations in patients with noninsulin-dependent diabetes mellitus.
    Jeng CY; Sheu WH; Jaspan JB; Polonsky KS; Chen YD; Reaven GM
    J Clin Endocrinol Metab; 1993 Jul; 77(1):6-10. PubMed ID: 8100832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of basal insulin supplementation on disposition of mixed meal in obese patients with NIDDM.
    McMahon M; Marsh HM; Rizza RA
    Diabetes; 1989 Mar; 38(3):291-303. PubMed ID: 2492963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.